Read the latest medical research on healthy bone and spine development. Find out about spinal problems and new treatment options.

GSK has claimed its second breakthrough designation from the FDA for antibody-drug conjugate GSK5764227, which it licensed from China's Hansoh Pharma in a $1.7 billion deal. The status has been ...